baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Knock-Out MRK/ DE000SD4MA27 /

2024-04-18 1:54:27 PM	Chg.-0.06	Bid1:54:52 PM	Ask1:54:52 PM	Underlying	Strike price	Expiration date	Option type
5.53EUR	-1.07%	5.54 Bid Size: 4,000	5.62 Ask Size: 4,000	Merck and Co Inc	66.063 USD	2078-12-31	Call

GlobeNewswire 04-15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness

GlobeNewswire 04-09 IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...

GlobeNewswire 04-05 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer

GlobeNewswire 04-03 TOMI Environmental Solutions Receives Gold Safety Award from Highwire

GlobeNewswire 04-02 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

TeleTrader 03-27 US opens higher after more housing data

GlobeNewswire 03-18 Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D...

GlobeNewswire 03-15 American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...

GlobeNewswire 03-06 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...

GlobeNewswire 03-05 IO Biotech Announces 2023 Fourth-Quarter and Year-End Results

GlobeNewswire 03-05 Sandoz announces nominations to the Board of Directors and leadership change

GlobeNewswire 02-26 IO Biotech to Present at 44th Annual Cowen Health Care Conference

GlobeNewswire 02-07 Alleo Labs Announces Publication on the Use of Artificial Intelligence in Neuroscience Drug Discover...

TeleTrader 02-01 US opens higher, recovers from Wednesday's losses

TeleTrader 02-01 Merck's Q4 sales up 6% to $14.6B

TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices

GlobeNewswire 01-09 C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted ...

GlobeNewswire 2023-12-21 IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial

GlobeNewswire 2023-12-07 Compass Pathways appoints Teri Loxam as Chief Financial Officer

GlobeNewswire 2023-12-04 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule

GlobeNewswire 2023-11-15 Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies

GlobeNewswire 2023-11-13 IO Biotech Announces 2023 Third Quarter Results

GlobeNewswire 2023-11-13 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire 2023-11-10 IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma

GlobeNewswire 2023-11-08 IO Biotech Announces Participation in Upcoming Investor Conferences

Soc. Generale Knock-Out MRK/ DE000SD4MA27 /

If you wish to receive reply to your feedback, please provide your email address.